The Preclinical Development Team at Kirilys Therapeutics is responsible for evaluating the safety, efficacy, and pharmacokinetic profiles of new cancer therapies before they enter clinical trials. This team, consisting of experts in pharmacology, toxicology, and ADME/PK, conducts comprehensive preclinical studies to optimize therapy regimens and ensure their potential for patient treatment.
View all